TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
LAB

Standard Biotools Inc

Healthcare · Medical Devices · —

0.7698$ +5.5% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Standard Biotools Inc (LAB): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/03/2026.

Next report 11/03/2026
Last report 08/05/2026
Earnings surprise by quarter (%)
Q3 23 · -16.7 % 23 Q4 23 · -92.3 % 23 Q1 24 · -140.0 % 24 Q2 24 · -14.3 % 24 Q3 24 · 57.1 % 24 Q4 24 · -64.7 % 24 Q1 25 · -25.0 % 25 Q2 25 · 0.0 % 25 Q3 25 · -100.0 % 25 Q4 25 · 226.1 % 25 Q1 26 · 0.0 % 26 Q2 26 · -66.7 % 26

EPS estimate beaten

Full history 25 of 62 quarters (40%)
Last 16 quarters 3 of 16 quarters (19%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/05/2026 STANDARD BIOTOOLS INC. (LAB): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/28/2026 STANDARD BIOTOOLS INC. (LAB): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/24/2026 STANDARD BIOTOOLS INC. (LAB): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?